IRIS
COSTA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.779
NA - Nord America 2.566
AS - Asia 1.990
SA - Sud America 627
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 9.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.481
RU - Federazione Russa 2.235
SG - Singapore 881
BR - Brasile 526
CN - Cina 416
IE - Irlanda 410
IT - Italia 331
HK - Hong Kong 260
SE - Svezia 229
VN - Vietnam 161
DE - Germania 133
FR - Francia 84
FI - Finlandia 71
IN - India 65
GB - Regno Unito 64
PL - Polonia 61
AT - Austria 48
CA - Canada 37
AR - Argentina 36
MX - Messico 34
BD - Bangladesh 28
MA - Marocco 25
TR - Turchia 24
ES - Italia 21
ID - Indonesia 20
ZA - Sudafrica 20
NL - Olanda 19
IQ - Iraq 18
UA - Ucraina 18
UZ - Uzbekistan 18
EC - Ecuador 16
BE - Belgio 14
CO - Colombia 14
PK - Pakistan 14
JP - Giappone 13
TN - Tunisia 10
EG - Egitto 9
KE - Kenya 9
LT - Lituania 9
MY - Malesia 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
VE - Venezuela 7
BO - Bolivia 6
JM - Giamaica 6
CL - Cile 5
IL - Israele 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
SA - Arabia Saudita 5
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
LB - Libano 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
DK - Danimarca 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
DZ - Algeria 2
GY - Guiana 2
HR - Croazia 2
MT - Malta 2
NG - Nigeria 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TG - Togo 1
Totale 9.052
Salva come PNG Salva come JPEG
Città #
Moscow 654
Ashburn 585
Singapore 433
Dublin 410
Dallas 278
Hong Kong 255
San Jose 211
Chandler 186
Nyköping 165
Messina 114
Beijing 105
The Dalles 92
Los Angeles 77
Ho Chi Minh City 62
Warsaw 58
Munich 57
New York 53
São Paulo 47
Lauterbourg 45
Hanoi 34
Dearborn 31
Vienna 31
Santa Clara 28
Rome 27
Bremen 26
Jacksonville 26
Princeton 26
Redondo Beach 26
Ann Arbor 25
Buffalo 25
Tianjin 24
Medford 23
Phoenix 23
Council Bluffs 22
Des Moines 22
Milan 20
Helsinki 19
London 19
Shanghai 19
Tashkent 18
Turku 18
Chennai 17
Denver 17
Frankfurt am Main 17
Rio de Janeiro 17
Belo Horizonte 15
Brasília 15
Brooklyn 15
Guangzhou 15
Montreal 15
Boardman 14
Brussels 14
Chicago 14
Lappeenranta 14
Nuremberg 14
Orem 14
Amsterdam 13
Houston 13
Cambridge 10
Campinas 10
Manchester 10
Mexico City 10
Porto Alegre 10
Springfield 10
Tokyo 10
Boston 9
Catania 9
Düsseldorf 9
Hangzhou 9
Pune 9
Stockholm 9
Atlanta 8
Hillsboro 8
Jakarta 8
Nairobi 8
Nanjing 8
Newark 8
Quito 8
Salvador 8
San Marcellino 8
Washington 8
Ankara 7
Da Nang 7
Goiânia 7
Hyderabad 7
Johannesburg 7
New Delhi 7
San Francisco 7
Shenzhen 7
Baghdad 6
Baku 6
Curitiba 6
Fort Worth 6
Los Lunas 6
Mumbai 6
Poplar 6
San Mateo 6
Seattle 6
Tunis 6
Altoona 5
Totale 4.997
Salva come PNG Salva come JPEG
Nome #
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 255
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 206
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 188
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 186
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 183
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 182
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 182
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 181
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 172
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 167
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 161
P1468Non-invasive myocardial work indices in ischemic heart disease 159
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 159
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 155
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 154
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 151
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 151
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 147
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 139
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 132
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 132
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 131
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 129
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 125
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 125
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 121
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 121
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 121
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 120
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 118
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 118
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 116
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 115
Left Main Coronary Artery 112
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 110
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 110
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 108
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 108
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 107
The High Bleeding Risk Patient with Coronary Artery Disease 106
Mental health status and sexual habits in young patient after acute coronary syndrome 103
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 101
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 101
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 98
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 96
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 96
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 96
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 94
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 93
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 92
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 91
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 87
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 85
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 84
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 83
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 81
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 81
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 80
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 80
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 78
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment 78
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 74
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 73
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 70
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 70
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 70
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol 69
Catheter-based techniques for pulmonary embolism treatment 64
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 60
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization 58
Vacuum-assisted thrombectomy of massive inferior vena cava thrombosis 49
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 48
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care 47
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 45
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 45
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 43
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 39
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 39
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 35
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 32
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 31
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 29
null 28
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 28
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke 26
Transfusion and Mortality After Transcatheter Aortic Valve Replacement 26
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 25
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 24
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 23
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 22
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 22
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 22
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI 22
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies 22
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 22
Inhibidores selectivos de la recaptacion de serotonina y riesgo hemorragico tras ICP. Un estudio con puntuacion de propension 21
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score 20
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19 20
Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE) 20
DAPT After PCI in High Bleeding Risk 19
Totale 9.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022207 2 15 15 6 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024340 21 27 17 39 24 73 70 16 8 21 1 23
2024/20251.696 20 14 16 150 110 135 74 220 368 126 155 308
2025/20265.662 345 313 407 417 463 1.175 619 715 653 319 153 83
Totale 9.335